Free Trial
NASDAQ:DMAAU

Drugs Made in America Acquisition (DMAAU) Stock Price, News & Analysis

Drugs Made in America Acquisition logo
$10.93 -0.06 (-0.51%)
Closing price 10/9/2026 03:58 PM Eastern
Extended Trading
$10.95 +0.02 (+0.15%)
As of 10/9/2026 05:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Drugs Made in America Acquisition Stock (NASDAQ:DMAAU)

Advanced

Key Stats

Today's Range
$10.99
▼
$10.99
50-Day Range
$10.79
▼
$11.00
52-Week Range
$10.30
▼
$12.50
Volume
N/A
Average Volume
5,100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Drugs Made in America Acquisition Corp. is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company operating in the pharmaceutical, biotechnology, medical device, or related healthcare sectors.

Unlike an operating drug manufacturer, the company does not appear to develop, manufacture, or market its own pharmaceutical products or healthcare services. Its principal activity is searching for a suitable acquisition target and pursuing a merger, acquisition, stock purchase, or similar transaction that could give investors exposure to an operating healthcare business.

The company was organized in the United States and has focused its stated investment strategy on opportunities connected to the domestic pharmaceutical and healthcare industries. Information about completed transactions, operating subsidiaries, products, geographic operations, and company leadership is limited in publicly available sources.

AI Generated. May Contain Errors.

Receive DMAAU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drugs Made in America Acquisition and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DMAAU Stock News Headlines

Location: United States
First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel
Drugs Made In America Acquisition Corp. Rt
Drugs Made In America Acquisition II Corp. Rt
See More Headlines

DMAAU Stock Analysis - Frequently Asked Questions

Drugs Made in America Acquisition's stock was trading at $10.49 at the start of the year. Since then, DMAAU shares have increased by 4.2% and is now trading at $10.9340.

Drugs Made in America Acquisition (DMAAU) raised $200 million in an initial public offering (IPO) on Tuesday, January 28th 2025. The company issued 20,000,000 shares at a price of $10.00 per share. Clear Street served as the underwriter for the IPO.

Shares of DMAAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:DMAAU
CIK
2028614
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
N/A
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:DMAAU) was last updated on 10/10/2026 by MarketBeat.com Staff.
From Our Partners